News

Union health minister Harsh Vardhan has said that the country is developing seven more Covid-19 vaccines to make them available to every citizen of India. “We are currently administering the Covishield and Covaxin vaccines to healthcare and frontline workers. The...

China’s national regulator has approved Sinovac Biotech’s COVID-19 vaccine for use by the general public. This is the second vaccine approved by China’s National Medical Products Administration (NMPA). Both of the vaccines, along with another experimental vaccine from Sinopharm, have...

Merck and BioNTech have announced a further expansion of their strategic partnership to accelerate the supply of urgently needed lipids and boost the amount of their delivery by the year-end. The lipids will be used for producing the Pfizer and...

TIACA and Pharma.Aero jointly release their second report for the global air cargo and pharmaceutical industries outlining recommended practices and insights for effective COVID-19 vaccine air transportation and handling. The report reinforces that COVID-19 vaccines are of high value and...

The newly formed Scientific Advisory Board (SAB) of Europital – a globally-focused, full-service CRO serving small and mid-tier innovators – forewarns that a clinical knowledge deficit amongst smaller biotechs will potentially slow trials in 2021. The Europital SAB, comprises a...

How can pharmaceutical companies leverage digital to engage HCPs in a complex healthcare environment? Digital transformation has been the leading topic of discussion in most industries this year, and healthcare is no exception. Although, it would be unfair to dismiss...

Bristol Myers Squibb announced that the U.S. FDA has approved Breyanzi, a CD19-directed chimeric antigen receptor (CAR) T cell therapy for the treatment of adult patients with relapsed or refractory (R/R) large B-cell lymphoma (LBCL) after two or more...